As lead investor in a series-A round, Chr. Augustinus Fabrikker, together with the existing investor group consisting of EIFO, Ugly Duckling Ventures and Sagitta, has invested over DKK 170m in the Danish-founded health tech company Eupry.
Eupry provides sensors that help monitor temperatures to comply with regulatory requirements and standards within the pharmaceutical, biotech and logistics sectors. Eupry was founded in 2014 and has approx. 50 employees.
Chr. Augustinus Fabrikker is a foundation-owned investment company with a broad ownership in Danish business enterprises and a philosophy of being engaged owners focusing on long-term value creation in Danish businesses with an international outlook.
The investment aims to strengthen Eupry’s position in the American market and further develop the product.
Accura advised Chr. Augustinus Fabrikker in connection with the investment.